EP3465214
Aðferðir til að spá fyrir um meðferðargagn and-CD19 meðferðar í sjúklingum
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
30.5.2017EP published:
28.4.2021EP application number:
17728484.1
EP translation filed:
5.7.2021Grant published:
15.8.2021EPO information:
European Patent Register
Max expiry date:
29.5.2037Expiry date:
29.5.2027Next due date:
31.5.2027
Title:
METHODS FOR PREDICTING THERAPEUTIC BENEFIT OF ANTI-CD19 THERAPY IN PATIENTS
Timeline
Today
30.5.2017EP application
28.4.2021EP Publication
5.7.2021Translation submitted
15.8.2021Registration published
29.5.2027Expires
Owner
Name:
Incyte CorporationAddress:
1801 Augustine Cut-Off, Wilmington, Delaware 19803, US
Inventor
Name:
ENDELL, JanAddress:
80333 München, DE
Name:
WINDERLICH, MarkAddress:
81373 München, DE
Name:
BOXHAMMER, RainerAddress:
83059 Kolbermoor, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
16171885Date:
30.5.2016Country:
EP
Classification
Categories:
G01N 33/574
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 28.5.2021
Expires: 29.5.2022
Payer: Sigurjónsson & Thor ehf.
Number: 6
Paid: 3.5.2022
Expires: 29.5.2023
Payer: Patice ehf.
Number: 7
Paid: 23.5.2023
Expires: 29.5.2024
Payer: Árnason Faktor ehf.
Number: 8
Paid: 23.5.2024
Expires: 29.5.2025
Payer: Árnason Faktor ehf.
Number: 9
Paid: 30.5.2025
Expires: 29.5.2026
Payer: Árnason Faktor ehf.
Number: 10
Paid: 19.5.2026
Expires: 29.5.2027
Payer: Árnason Faktor ehf.